Follow on Google News News By Tag * Digital Pathology * Biomarker Development * Clinical Research * Biotechnology * Pharmaceutical * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Pathology Diagnostics Ltd (PDL) Wins Prestigious Biomedical Catalyst (BMC) Scheme AwardPathology Diagnostics Ltd is one of the earliest SME recipients of the £180 million Technology Strategy Board (the UK’s Innovation Agency) Biomedical Catalyst funding programme; winning a Biomedical Catalyst feasibility award in the second round.
For further information on awards made through the Biomedical Catalyst, please click here (https://www.innovateuk.org/-/ The Technology Strategy Board is the UK’s innovation agency. Its goal is to accelerate economic growth by stimulating and supporting business-led innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org --- END --- Notes to editors and media: Pathology Diagnostics Ltd is an independent GCLP accredited UK research SME engaged in innovative healthcare and pharmaceutical research. We also deliver high-quality tissue laboratory & diagnostics to industry Research & Development scientists engaged in drug and biomarker development. Specialising in the provision of clinical diagnostics and quantitative image analysis on human tissues for studies ranging from early discovery to clinical trials, Pathology Diagnostics has a wide range of technical capabilities from traditional histopathology techniques to advanced digital pathology, whole slide scanning, central biorepository services and quantitative image analysis of biomarkers. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|